RSS-Feed abonnieren
DOI: 10.1055/s-0043-109557
Production of the Cytotoxic Cardenolide Glucoevatromonoside by Semisynthesis and Biotransformation of Evatromonoside by a Digitalis lanata Cell Culture[*]
Publikationsverlauf
received 31. Januar 2017
revised 31. März 2017
accepted 12. April 2017
Publikationsdatum:
09. Mai 2017 (online)
Abstract
Recent studies demonstrate that cardiac glycosides, known to inhibit Na+/K+-ATPase in humans, have increased susceptibility to cancer cells that can be used in tumor therapy. One of the most promising candidates identified so far is glucoevatromonoside, which can be isolated from the endangered species Digitalis mariana ssp. heywoodii. Due to its complex structure, glucoevatromonoside cannot be obtained economically by total chemical synthesis. Here we describe two methods for glucoevatromonoside production, both using evatromonoside obtained by chemical degradation of digitoxin as the precursor. 1) Catalyst-controlled, regioselective glycosylation of evatromonoside to glucoevatromonoside using 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide as the sugar donor and 2-aminoethyldiphenylborinate as the catalyst resulted in an overall 30 % yield. 2) Biotransformation of evatromonoside using Digitalis lanata plant cell suspension cultures was less efficient and resulted only in overall 18 % pure product. Structural proof of products has been provided by extensive NMR data. Glucoevatromonoside and its non-natural 1–3 linked isomer neo-glucoevatromonoside obtained by semisynthesis were evaluated against renal cell carcinoma and prostate cancer cell lines.
Key words
Cardiac glycosides - Digitalis mariana - Digitalis lanata - Plantaginaceae - regioselective glycosylation - plant cell suspension culture* Dedicated to Professor Dr. Max Wichtl in recognition of his outstanding contribution to pharmacognosy research.
** These authors contributed equally to this manuscript.
Supporting Information
- Supporting Information
UPLC/MS data and HPLC-DAD chromatograms obtained for compounds 1–6, isolation and purification protocol for compound 1, a plot of the HMQC-NMR spectrum of compound 2 as well as the dose-response curves of MTT assays for compounds 2–4 and the conditions of the Na+/K+-ATPase assay along with the bar graphs for compounds 1–4 are available as Supporting Information. Detailed descriptions of EV (2) synthesis and experimental conditions of UPLC-ESI-MS, HPLC, TLC, and NMR analysis are also provided as Supporting Information.
-
References
- 1 Ehle M, Patel C, Giugliano RP. Digoxin: clinical highlights: a review of digoxin and its use in contemporary medicine. Crit Pathw Cardiol 2011; 10: 93-98
- 2 Ashbrook AW, Lentscher AJ, Zamora PF, Silva LA, May NA, Bauer JA, Morrison TE, Dermody TS. Antagonism of the sodium-potassium ATPase impairs chikungunya virus infection. MBio 2016; 7: e00693-16
- 3 Cheung YY, Chen KC, Chen H, Seng EK, Chu JJH. Antiviral activity of lanatoside C against dengue virus infection. Antiviral Res 2014; 111: 93-99
- 4 Wong RW, Balachandran A, Ostrowski MA, Cochrane A. Digoxin suppresses HIV-1 replication by altering viral RNA processing. PLoS Pathog 2013; 9: e1003241
- 5 Bertol JW, Rigotto C, de Padua RM, Kreis W, Barardi CRM, Braga FC, Simoes CMO. Antiherpes activity of glucoevatromonoside, a cardenolide isolated from a Brazilian cultivar of Digitalis lanata . Antiviral Res 2011; 92: 73-80
- 6 Su CT, Hsu JT, Hsieh HP. Anti-HSV activity of digitoxin and its possible mechanisms. Antiviral Res 2008; 79: 62-70
- 7 Diederich M, Muller F, Cerella C. Cardiac glycosides: From molecular targets to immunogenic cell death. Biochem Pharmacol 2017; 125: 1-11
- 8 Calderon-Montano JM, Burgos-Moron E, Orta ML, Maldonado-Navas D, Garcia-Dominguez I, Lopez-Lazaro M. Evaluating the cancer therapeutic potential of cardiac glycosides. Biomed Res Int 2014; 2014: 794930
- 9 Cerella C, Dicato M, Diederich M. Assembling the puzzle of anti-cancer mechanisms triggered by cardiac glycosides. Mitochondrion 2013; 13: 225-234
- 10 Mijatovic T, Dufrasne F, Kiss R. Cardiotonic steroids-mediated targeting of the Na(+)/K(+)-ATPase to combat chemoresistant cancers. Curr Med Chem 2012; 19: 627-646
- 11 Elbaz HA, Stueckle TA, Tse W, Rojanasakul Y, Dinu CZ. Digitoxin and its analogs as novel cancer therapeutics. Exp Hematol Oncol 2012; 1: 4
- 12 Schneider NFZ, Geller FC, Persich L, Marostica LL, Padua RM, Kreis W, Braga FC, Simoes CMO. Inhibition of cell proliferation, invasion and migration by the cardenolides digitoxigenin monodigitoxoside and convallatoxin in human lung cancer cell line. Nat Prod Res 2016; 30: 1327-1331
- 13 Wang HY, Xin W, Zhou M, Stueckle TA, Rojanasakul Y, OʼDoherty GA. Stereochemical survey of digitoxin monosaccharides: new anticancer analogues with enhanced apoptotic activity and growth inhibitory effect on human non-small cell lung cancer cell. ACS Med Chem Lett 2011; 2: 73-78
- 14 Schneider NFZ. Avaliação da ação citotóxica de cardenolídeos em células tumorais [thesis]. Florianópolis: Universidade Federal de Santa Catarina; 2015
- 15 Braga FC, Kreis W, Braga de Oliveira A. Isolation of cardenolides from a Brazilian cultivar of Digitalis lanata by rotation locular counter-current chromatography. J Chromatogr A 1996; 756: 287-291
- 16 Luckner M, Wichtel M. Digitalis . Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH; 2003
- 17 Kreis W, Haug B, Yücesan B. Somaclonal variation of cardenolide content in Heywoodʼs foxglove, a source for the antiviral cardenolide glucoevatromonoside, regenerated from permanent shoot culture and callus. In Vitro Cell Dev Biol Plant 2014; 51: 35-41
- 18 Beale TM, Taylor MS. Synthesis of cardiac glycoside analogs by catalyst-controlled, regioselective glycosylation of digitoxin. Org Lett 2013; 15: 1358-1361
- 19 Zhou M, OʼDoherty GA. A stereoselective synthesis of digitoxin and digitoxigen mono- and bisdigitoxoside from digitoxigenin via a palladium-catalyzed glycosylation. Org Lett 2006; 8: 4339-4342
- 20 Daisuke Satho. Pharmaceutical Compositions. United States Patent US 3,856,944, 1974
- 21 Gantt RW, Peltier-Pain P, Cournoyer WJ, Thorson JS. Using simple donors to drive the equilibria of glycosyltransferase-catalyzed reactions. Nat Chem Biol 2011; 7: 685-691
- 22 Gantt RW, Peltier-Pain P, Thorson JS. Enzymatic methods for glyco(diversification/randomization) of drugs and small molecules. Nat Prod Rep 2011; 28: 1811-1853
- 23 Shilpa K, Varun K, Lakshmi BS. An alternate method of natural drug production: Elciting secondary metabolite production using plant cell culture. J Plant Sci 2010; 5: 222-247
- 24 Padua RM, Meitinger N, Dias de Souza JF, Waibel R, Gmeiner P, Braga FC, Kreis W. Biotransformation of 21-O-acetyl-deoxycorticosterone by cell suspension cultures of Digitalis lanata (strain W.1.4). Steroids 2012; 77: 1373-1380
- 25 Kreis W, Fulzele D, Hoelz H, Val J, Reinhard E. Production of Cardenolides by Digitalis Cell Cultures – Models and Process Options. In: Oono K, Hirabayashi T, Kikuchi S, Handa H, Kajiwara K. eds. Plant Tissue Culture and Gene Manipulation for Breeding and Formation of Phytochemicals. Tsukuba: National Institute of Agrobiological Resources (NIAR); 1992: 335-354
- 26 Kreis W, Reinhard E. 12 beta-Hydroxylation of digitoxin by suspension-cultured Digitalis lanata cells: production of digoxin in 20-litre and 300-litre air-lift bioreactors. J Biotechnol 1992; 26: 257-273
- 27 Theurer C, Treumann HJ, Faust T, May U, Kreis W. Glycosylation in cardenolide biosynthesis. PCTOC 1994; 38: 327-335
- 28 Kreis W, Reinhard E. 12beta-Hydroxylation of digitoxin by suspension-cultured Digitalis lanata cells. Production of deacetyllanatoside C using a two-stage culture method. Planta Med 1988; 54: 143-148
- 29 Kreis W, May U, Reinhard E. UDP-glucose: digitoxin 16′-O-glucosyltransferase from suspension-cultured Digitalis lanata cells. Plant Cell Rep 1986; 5: 442-445
- 30 Theurer C, Kreis W, Reinhard E. Effects of digitoxigenin, digoxigenin, and various cardiac glycosides on cardenolide accumulation in shoot cultures of Digitalis lanata . Planta Med 1998; 64: 705-710
- 31 Munkert J, Ernst M, Muller-Uri F, Kreis W. Identification and stress-induced expression of three 3beta-hydroxysteroid dehydrogenases from Erysimum crepidifolium Rchb. and their putative role in cardenolide biosynthesis. Phytochemistry 2014; 100: 26-33
- 32 Singh S, Vishwakarma RK, Kumar RJS, Sonawane PD, Ruby. Khan BM. Functional characterization of a flavonoid glycosyltransferase gene from Withania somnifera (Ashwagandha). Appl Biochem Biotechnol 2013; 170: 729-741
- 33 Sharma LK, Madina BR, Chaturvedi P, Sangwan RS, Tuli R. Molecular cloning and characterization of one member of 3beta-hydroxy sterol glucosyltransferase gene family in Withania somnifera . Arch Biochem Biophys 2007; 460: 48-55
- 34 Lim EK, Ashford DA, Hou B, Jackson RG, Bowles DJ. Arabidopsis glycosyltransferases as biocatalysts in fermentation for regioselective synthesis of diverse quercetin glucosides. Biotechnol Bioeng 2004; 87: 623-631
- 35 Nolte E, Sobel A, Wach S, Hertlein H, Ebert N, Muller-Uri F, Slany R, Taubert H, Wullich B, Kreis W. The new semisynthetic cardenolide analog 3beta-2-(1-Amantadine)-1-on-ethylamine-digitoxigenin (AMANTADIG) efficiently suppresses cell growth in human leukemia and urological tumor cell lines. Anticancer Res 2015; 35: 5271-5275
- 36 Nolte E, Wach S, Thais Silva I, Lukat S, Ekici AB, Munkert J, Muller-Uri F, Kreis W, Simoes CMO, Vera J, Wullich B, Taubert H, Lai X. A new semisynthetic cardenolide analog 3beta-2-(1-amantadine)-1-on-ethylamine-digitoxigenin (AMANTADIG) affects G2/M cell cycle arrest and miRNA expression profiles and enhances proapoptotic survivin-2B expression in renal cell carcinoma cell lines. Oncotarget 2017; 8: 11676-11691
- 37 Katz A, Lifshitz Y, Bab-Dinitz E, Kapri-Pardes E, Goldshleger R, Tal DM, Karlish SJD. Selectivity of digitalis glycosides for isoforms of human Na,K-ATPase. J Biol Chem 2010; 285: 19582-19592
- 38 Laursen M, Yatime L, Nissen P, Fedosova NU. Crystal structure of the high-affinity Na+K+-ATPase-ouabain complex with Mg2+ bound in the cation binding site. Proc Natl Acad Sci U S A 2013; 110: 10958-10963
- 39 Yatime L, Laursen M, Morth JP, Esmann M, Nissen P, Fedosova NU. Structural insights into the high affinity binding of cardiotonic steroids to the Na+,K+-ATPase. J Struct Biol 2011; 174: 296-306
- 40 Toyoshima C, Cornelius F. New crystal structures of PII-type ATPases: excitement continues. Curr Opin Struct Biol 2013; 23: 507-514
- 41 Yoda A. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. I. Dissociation rate constants of various enzyme-cardiac glycoside complexes formed in the presence of magnesium and phosphate. Mol Pharmacol 1973; 9: 51-60
- 42 Cornelius F, Kanai R, Toyoshima C. A structural view on the functional importance of the sugar moiety and steroid hydroxyls of cardiotonic steroids in binding to Na,K-ATPase. J Biol Chem 2013; 288: 6602-6616
- 43 Baykov AA, Evtushenko OA, Avaeva SM. A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay. Anal Biochem 1988; 171: 266-270